Showing results (31-40 of 82) with videos related to
Sort By:
Pageof 9
Open Medicine (Warsaw, Poland)|March 30, 2017
Endobronchial amyloidosis mimicking bronchial asthma: a case report and review of the literatureHyun-Wook Kang, Hyung-Joo Oh, Ha Young Park, et al.Cancers|February 25, 2023
Blood-Based Biomarker Analysis for Predicting Efficacy of Chemoradiotherapy and Durvalumab in Patients with Unresectable Stage III Non-Small Cell Lung CancerCheol-Kyu Park, Sung-Woo Lee, Hyun-Ju Cho, et al.Journal of Thoracic Disease|June 14, 2016
Different characteristics associated with intensive care unit transfer from the medical ward between patients with acute exacerbations of chronic obstructive pulmonary disease with and without pneumoniaHong-Joon Shin, Cheol-Kyu Park, Tae-Ok Kim, et al.Thoracic Cancer|November 12, 2015
Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitorWoo-Jin Kim, Sunmin Kim, Hayoung Choi, et al.Experimental & Molecular Medicine|April 30, 2025
Progressive accumulation of circulating CD27-CD28- effector/memory CD8+ T cells in patients with lung cancer blunts responses to immune checkpoint inhibitor therapySung-Woo Lee, Ju Sik Yun, Young Ju Kim, et al.Journal of Korean Medical Science|January 1, 2019
Clinical Validation of a Protein Biomarker Panel for Non-Small Cell Lung CancerYoung Ju Jung, In-Jae Oh, Youndong Kim, et al.Thoracic Cancer|October 11, 2025
Real-World Outcomes of Brigatinib Compared to Alectinib as a Second-Line Therapy After Crizotinib in Advanced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer PatientsMin Jee Kim, Hyun Seok Kwak, Eun Nim Koh, et al.Clinical Lung Cancer|August 29, 2018
Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung AdenocarcinomaIn-Jae Oh, Jae Young Hur, Cheol-Kyu Park, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
Nicotinamide in Combination with EGFR-TKIs for the Treatment of Stage IV Lung Adenocarcinoma with EGFR Mutations: A Randomized Double-Blind (Phase IIb) TrialHyung-Joo Oh, Suk-Chul Bae, In-Jae Oh, et al.Plos One|August 17, 2016
Microbiological Characteristics and Predictive Factors for Mortality in Pleural Infection: A Single-Center Cohort Study in KoreaCheol-Kyu Park, Hyoung-Joo Oh, Ha-Young Choi, et al.Pageof 9